Ticlopidine antiplatelets drug

Ticlid - 5332C - 53 32C - 53-32C - Ticlodone - Ticlodix - Ticlopidine Hydrochloride - Ticlopidine      

pdf
pathology Demonstrated benefit and harm k      
acute coronary syndrome

versus placebo or control

No demonstrated result for efficacy

3 trialsmeta-analysis
acute myocardial infarction

versus placebo or control

No demonstrated result for efficacy

1 trialmeta-analysis
CABG surgery

versus placebo or control

No demonstrated result for efficacy

6 trialsmeta-analysis
cardiovascular prevention

versus placebo or control

No demonstrated result for efficacy

17 trialsmeta-analysis
coronary artery disease

versus placebo or control

No demonstrated result for efficacy

1 trialmeta-analysis
diabetes type 2

versus placebo or control

No demonstrated result for efficacy

5 trialsmeta-analysis
percutaneous coronary intervention

versus placebo or control

No demonstrated result for efficacy

2 trialsmeta-analysis
percutaneous coronary intervention

versus anticoagulant + antiplatelet

No demonstrated result for efficacy

5 trialsmeta-analysis
percutaneous coronary intervention

versus antiplatelet drugs

No demonstrated result for efficacy

2 trialsmeta-analysis
peripheral vascular diseases

versus

No demonstrated result for efficacy

1 trialmeta-analysis
peripheral vascular diseases

versus placebo or control

No demonstrated result for efficacy

11 trialsmeta-analysis
stable angina

versus placebo or control

No demonstrated result for efficacy

1 trialmeta-analysis
stent

versus anticoagulant + antiplatelet

No demonstrated result for efficacy

5 trialsmeta-analysis
stent

versus antiplatelet drugs

No demonstrated result for efficacy

2 trialsmeta-analysis
thrombosis prevention

versus

No demonstrated result for efficacy

1 trialmeta-analysis
thrombosis prevention

versus placebo or control

No demonstrated result for efficacy

2 trialsmeta-analysis
thrombosis prevention

versus placebo or no treatment

No demonstrated result for efficacy

3 trialsmeta-analysis